Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > new board director - new money ideas....
View:
Post by DJDawg on Jun 08, 2023 8:37pm

new board director - new money ideas....

Looked up a bit more about Dr. Lbiati

From
https://biotuesdays.com/2022/06/28/hepion-adds-accomplished-biopharmaceutical-executives-anand-reddi-and-dr-kaouthar-lbiati-to-board/

"Most recently, Dr. Lbiati served as a strategic advisor to several biotech companies and venture capital firms. She headed portfolio strategy at Steba Biotech; served as a medical technology investment consultant to Forepont Capital Partners; and was director, strategic market access at Amari."

Forepont is an example of a VC firm funding early biotechs.

I generally don't get excited about anything management does these days but I am excited by the fact the the new addition to the board has significant venture capital connections. As in she may be able to give the team ideas for raising capital and ramping things up for the big-time.

I suspect that money is the main reason that there has not been an IND application for the IV version of TLD-1433. I suspect that money is the main reason why there are not more recruitement sites for the main NMIBC study. More money means that they can move some things along. IMO

Comment by patience69 on Jun 08, 2023 9:50pm
Thanks for that research & for sharing DJ. This does sound interesting
Comment by fecats on Jun 08, 2023 10:07pm
Excellent find Dawg !!
Comment by ScienceFirst on Jun 08, 2023 10:10pm
TLT, just like any other company, plans ahead, months in advance. There's a clear execution path regarding biotechs.  Different strategies, but clear execution. Even before they started Ph. 1B, Roger stated in a Midas Letter interview the reason why they would go all alone till Ph. 2.  Because they knew they had something different regarding the mechanism of this molecule ...more  
Comment by Gooseybear on Jun 09, 2023 6:19am
I hope TLT uses your post as a PR release. 
Comment by Gooseybear on Jun 09, 2023 6:19am
SF I hope TLT uses your post as a PR release.
Comment by Oilminerdeluxe on Jun 09, 2023 12:33pm
How many in our little cult are going to the AGM? Hopefully, it will be a joyous occasion.
Comment by DJDawg on Jun 09, 2023 3:39pm
I cannot. I do have questions. I wonder if anyone going can carry forward some questions that the forum generally agrees would be helpful. I assume that these things have a Q and A but I don't know.
Comment by Jaro1977 on Jun 09, 2023 4:52pm
Hi DJ, I will probably go.  Let me know what questions you have and I will ask them.
Comment by DJDawg on Jun 09, 2023 4:59pm
great. I will start a new thread so that we can adjust a master list of questions from those who are not attending.
Comment by Eoganacht on Jun 10, 2023 3:14pm
Thanks for the kind offer to ask the questions Jaro1977 and thanks DJDawg for compiling the questions.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250